When you buy through links on our articles, Future and its syndication partners may earn a commission. In patients with Lesch-Nyhan syndrome, the HPRT1 enzyme doesn't work properly due to mutations in ...
Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure. The company’s Ingrezza (valbenazine), approved to treat certain uncontrolled movement ...
Tardive dyskinesia is a medication-induced movement disorder that causes uncontrollable muscle movements in the face, neck, and limbs. Symptoms may continue even after stopping the medication. Tardive ...
University of Arizona researchers have revealed new insights into the neurobiological cause of the involuntary, uncontrollable movement disorders that develop in patients with Parkinson’s disease (PD) ...
Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new insights ...